4basebio and Genezen Partner to Develop Synthetic DNA Platforms for Viral Vector Manufacturing

Biotech firms 4basebio and Genezen have formed a strategic alliance to advance cell-free, synthetic DNA technologies aimed at improving next-generation viral vector production.

26 Aug, 06:20 — 26 Aug, 06:20

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual1h ago

4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing - Taiwan News

4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing Taiwan News

Read full article →

PERSPECTA

PERSPECTA

4basebio and Genezen Partner to Develop Synthetic DNA Platforms for Viral Vector Manufacturing

Sources

4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing - Taiwan News

Related Stories

Under-16 Social Media Use Rises Despite Australian Ban

Meta and US States Negotiate Settlement Over Teen Social Media Harm Lawsuits

SpaceX Plans $100 Billion Starship Launch Complex in Louisiana

ParaZero Secures First U.S. Contract for DefendAir Counter-Drone System

PERSPECTA